drugset / Trial / NCT06403501
Efficacy and Safety of Clascoterone Cream 1% in Facial Acne Vulgaris
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of this study is to determine the safety and efficacy of clascoterone cream, 1%, versus the vehicle cream applied twice daily for 12 weeks in subjects with facial acne vulgaris.
Timeline
- Start
- 2024-05-20
- Primary completion
- 2026-10
- Completion
- 2026-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clascoterone | Small molecule | 1 % | Topical |